Publications by authors named "K-F Tse"
Article Synopsis
- ADA deficiency (ADA-SCID) is a serious and rare condition affecting the immune system, requiring innovative treatments like gene therapy.
- Researchers treated 50 ADA-SCID patients using a method involving their own modified stem cells and saw a 100% survival rate over 24-36 months, with high levels of event-free survival and successful immune reconstitution.
- The study concluded that this gene therapy is effective and safe, with minimal adverse effects and no serious complications reported, highlighting its potential as a promising treatment for ADA-SCID.
Background And Purpose: We evaluated modifications to our contrast-enhanced MR imaging grading system for symptomatic patients with suspected nasopharyngeal carcinoma, aimed at improving discrimination of early-stage cancer and benign hyperplasia. We evaluated a second non-contrast-enhanced MR imaging grading system for asymptomatic patients from nasopharyngeal carcinoma plasma screening programs.
Materials And Methods: Dedicated nasopharyngeal MR imaging before (plain scan system) and after intravenous contrast administration (current and modified systems) was reviewed in patients from a nasopharyngeal carcinoma-endemic region, comprising 383 patients with suspected disease without nasopharyngeal carcinoma and 383 patients with nasopharyngeal carcinoma.